{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T18:50:45Z","timestamp":1792263045132,"version":"4.4.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-09835-w","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T10:14:49Z","timestamp":1753352089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacological Evaluation of active compounds in papaya associated with thrombocytopenia inhibition in dengue patients through in silico approaches"],"prefix":"10.1038","volume":"15","author":[{"given":"Md. Anisur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Bastos","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Vin\u00edcius","family":"Rolim Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamal A.","family":"Al-Mutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahina","family":"Akter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endalamaw","family":"Yihune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdi E. A.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas Ivan Nobre","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"issue":"3","key":"9835_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.bbapap.2013.12.013","volume":"1844","author":"M Elahi","year":"2014","unstructured":"Elahi, M. et al. Computational prediction and experimental characterization of a size switch type repacking during the evolution of dengue envelope protein domain III (ED3), Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1844(3), 585\u2013592 (2014).","journal-title":"Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics"},{"issue":"948","key":"9835_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/pgmj.2004.019638","volume":"80","author":"G Malavige","year":"2004","unstructured":"Malavige, G., Fernando, S., Fernando, D. & Seneviratne, S. Dengue viral infections. Postgrad. Med. J. 80 (948), 588\u2013601 (2004).","journal-title":"Postgrad. Med. J."},{"issue":"12","key":"9835_CR3","first-page":"S7","volume":"8","author":"MEG Siritt","year":"2010","unstructured":"Siritt, M. E. G. et al. Dengue: a continuing global threat. Nat. Rev. Microbiol. 8 (12), S7\u2013S16 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"9835_CR4","doi-asserted-by":"crossref","unstructured":"Kularatne, S. Dengue fever. Bmj. 351; h4661, ed, (2015).","DOI":"10.1136\/bmj.h4661"},{"issue":"3","key":"9835_CR5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.cell.2015.07.005","volume":"162","author":"MS Diamond","year":"2015","unstructured":"Diamond, M. S. & Pierson, T. C. Molecular insight into dengue virus pathogenesis and its implications for disease control. Cell 162(3), 488\u2013492 (2015).","journal-title":"Cell"},{"issue":"1","key":"9835_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mjafi.2014.09.011","volume":"71","author":"M Mustafa","year":"2015","unstructured":"Mustafa, M., Rasotgi, V., Jain, S. & Gupta, V. Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Med. J. Armed Forces India. 71 (1), 67\u201370 (2015).","journal-title":"Med. J. Armed Forces India"},{"key":"9835_CR7","doi-asserted-by":"crossref","unstructured":"Banjan, B. et al. In-silico screening and identification of potential drug-like compounds for dengue-associated thrombocytopenia from Carica papaya leaf extracts. Journal Biomol. Struct. Dynamics, 42 pp. 1\u201319, (2023).","DOI":"10.1080\/07391102.2023.2230293"},{"key":"9835_CR8","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00109-016-1409-0","volume":"94","author":"YL Huang","year":"2016","unstructured":"Huang, Y. L. et al. CLEC5A is critical for dengue virus-induced osteoclast activation and bone homeostasis. J. Mol. Med. 94, 1025\u20131037 (2016).","journal-title":"J. Mol. Med."},{"key":"9835_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.virusres.2016.07.001","volume":"223","author":"HFS Souza","year":"2016","unstructured":"Souza, H. F. S., da Silva Almeida, B. & Boscardin, S. B. Early dengue virus interactions: the role of dendritic cells during infection. Virus Res. 223, 88\u201398 (2016).","journal-title":"Virus Res."},{"issue":"5","key":"9835_CR10","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.4049\/jimmunol.1201542","volume":"190","author":"R Tallerico","year":"2013","unstructured":"Tallerico, R. et al. Human NK cells selective targeting of colon cancer\u2013initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules. J. Immunol. 190 (5), 2381\u20132390 (2013).","journal-title":"J. Immunol."},{"issue":"5","key":"9835_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/bies.201400182","volume":"37","author":"DL Akey","year":"2015","unstructured":"Akey, D. L. et al. Structure-guided insights on the role of NS1 in flavivirus infection. Bioessays 37(5), 489\u2013494 (2015).","journal-title":"Bioessays"},{"key":"9835_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-018-0462-0","volume":"25","author":"HR Chen","year":"2018","unstructured":"Chen, H. R., Lai, Y. C. & Yeh, T. M. Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate. J. Biomed. Sci. 25, 1\u201311 (2018).","journal-title":"J. Biomed. Sci."},{"issue":"3","key":"9835_CR13","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J. Nat. Prod. 83 (3), 770\u2013803 (2020).","journal-title":"J. Nat. Prod."},{"key":"9835_CR14","doi-asserted-by":"crossref","unstructured":"Hussain, N. et al. Bioactive antidiabetic flavonoids from the stem bark of Cordia dichotoma Forst.: Identification, docking and ADMET studies, Molbank, vol. no. 2, p. M1234, 2021. (2021).","DOI":"10.3390\/M1234"},{"key":"9835_CR15","doi-asserted-by":"publisher","first-page":"1185236","DOI":"10.3389\/fnut.2023.1185236","volume":"10","author":"R Baru Venkata","year":"2023","unstructured":"Baru Venkata, R. et al. Utilizing Andrographis paniculata leaves and roots by effective usage of the bioactive Andrographolide and its nanodelivery: investigation of antikindling and antioxidant activities through in Silico and in vivo studies. Front. Nutr. 10, 1185236 (2023).","journal-title":"Front. Nutr."},{"issue":"1","key":"9835_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/26895293.2020.1856192","volume":"14","author":"SYM Lim","year":"2021","unstructured":"Lim, S. Y. M., Chieng, J. Y. & Pan, Y. Recent insights on anti-dengue virus (DENV) medicinal plants: review on in vitro, in vivo and in Silico discoveries. All Life. 14 (1), 1\u201333 (2021).","journal-title":"All Life"},{"key":"9835_CR17","doi-asserted-by":"crossref","unstructured":"Sharma, A. et al. Carica papaya L. leaves: Deciphering its antioxidant bioactives, biological activities, innovative products, and safety aspects, Oxidative medicine and cellular longevity, vol. no. 1, p. 2451733, 2022. (2022).","DOI":"10.1155\/2022\/2451733"},{"key":"9835_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.6000\/1927-5129.2018.14.33","volume":"14","author":"U Fatima","year":"2018","unstructured":"Fatima, U. & Shahid, S. Pharmacological activities of Carica papaya Linn. J. Basic. Appl. Sci. 14, 210\u2013216 (2018).","journal-title":"J. Basic. Appl. Sci."},{"key":"9835_CR19","doi-asserted-by":"crossref","unstructured":"Dharmapalan, B. T. et al. Inhibitory potential of chromene derivatives on structural and non-structural proteins of dengue virus, Viruses, vol. 14, no. 12, p. 2656, (2022).","DOI":"10.3390\/v14122656"},{"key":"9835_CR20","doi-asserted-by":"crossref","unstructured":"Ninfali, P., Antonelli, A., Magnani, M. & Scarpa, E. S. Antiviral properties of flavonoids and delivery strategies, Nutrients, vol. 12, no. 9, p. 2534, (2020).","DOI":"10.3390\/nu12092534"},{"key":"9835_CR21","doi-asserted-by":"crossref","unstructured":"Senthilvel, P. et al. Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents Dengue 2 viral assembly, Bioinformation, vol. 9, no. 18, p. 889, (2013).","DOI":"10.6026\/97320630009889"},{"issue":"3","key":"9835_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4103\/ijmr.ijmr_2406_21","volume":"156","author":"N Shrivastava","year":"2022","unstructured":"Shrivastava, N., Alagarasu, K., Cherian, S. & Parashar, D. Antiviral & platelet-protective properties of Carica papaya in dengue. Indian J. Med. Res. 156 (3), 459\u2013463 (2022).","journal-title":"Indian J. Med. Res."},{"issue":"6","key":"9835_CR23","doi-asserted-by":"publisher","first-page":"bbab199","DOI":"10.1093\/bib\/bbab199","volume":"22","author":"W Zheng","year":"2021","unstructured":"Zheng, W., Wu, H., Wang, T., Zhan, S. & Liu, X. Quercetin for COVID-19 and DENGUE co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and DENV. Brief. Bioinform. 22 (6), bbab199 (2021).","journal-title":"Brief. Bioinform."},{"key":"9835_CR24","doi-asserted-by":"crossref","unstructured":"Teh, B. P. et al. Carica papaya leaf juice for dengue: a scoping review, Nutrients, vol. 14, no. 8, p. 1584, (2022).","DOI":"10.3390\/nu14081584"},{"issue":"1","key":"9835_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40794-024-00232-1","volume":"10","author":"B Rehman","year":"2024","unstructured":"Rehman, B. et al. Exploring plant-based dengue therapeutics: from laboratory to clinic. Trop. Dis. Travel Med. Vaccines. 10 (1), 23 (2024).","journal-title":"Trop. Dis. Travel Med. Vaccines"},{"issue":"8","key":"9835_CR26","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.3390\/ijms25084376","volume":"25","author":"J Starvaggi","year":"2024","unstructured":"Starvaggi, J., Previti, S., Zappal\u00e0, M. & Ettari, R. The Inhibition of NS2B\/NS3 protease: A new therapeutic opportunity to treat dengue and Zika virus infection. Int. J. Mol. Sci. 25 (8), 4376 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"9835_CR27","doi-asserted-by":"publisher","first-page":"1061937","DOI":"10.3389\/fcimb.2023.1061937","volume":"13","author":"H Norshidah","year":"2023","unstructured":"Norshidah, H. et al. Assessing the potential of NS2B\/NS3 protease inhibitors biomarker in curbing dengue virus infections: in Silico vs. in vitro approach. Front. Cell. Infect. Microbiol. 13, 1061937 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"9835_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4103\/0972-9062.184848","volume":"53","author":"VD Dwivedi","year":"2016","unstructured":"Dwivedi, V. D., Tripathi, I. P. & Mishra, S. K. In Silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease. J. Vector Borne Dis. 53 (2), 156\u2013161 (2016).","journal-title":"J. Vector Borne Dis."},{"key":"9835_CR29","doi-asserted-by":"crossref","unstructured":"Bari, M. A. et al. Novel antiviral phytochemicals against dengue virus 2 NS2B-NS3 protease: an in Silico drug development approach, ChemistrySelect, 9, 47, p. e202404053, (2024).","DOI":"10.1002\/slct.202404053"},{"key":"9835_CR30","doi-asserted-by":"crossref","unstructured":"Pereira, L. R. et al. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 dengue virus nonstructural protein 1, Vaccines, vol. 8, no. 4, p. 565, (2020).","DOI":"10.3390\/vaccines8040565"},{"key":"9835_CR31","doi-asserted-by":"crossref","unstructured":"Kim, S. et al. PubChem 2025 update. Nucleic Acids Research, 53, no. (2025). D1, pp. D1516-D1525.","DOI":"10.1093\/nar\/gkae1059"},{"issue":"3","key":"9835_CR32","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1063\/1.462066","volume":"96","author":"AD Becke","year":"1992","unstructured":"Becke, A. D. Density-functional thermochemistry. I. The effect of the exchange\u2010only gradient correction. J. Chem. Phys. 96 (3), 2155\u20132160 (1992).","journal-title":"J. Chem. Phys."},{"issue":"18","key":"9835_CR33","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1021\/jp0037549","volume":"105","author":"UD Priyakumar","year":"2001","unstructured":"Priyakumar, U. D. & Sastry, G. N. First Ab initio and density functional study on the structure, bowl-to-bowl inversion barrier, and vibrational spectra of the elusive C 3 v-Symmetric buckybowl: sumanene, C21H12. J. Phys. Chem. A. 105 (18), 4488\u20134494 (2001).","journal-title":"J. Phys. Chem. A"},{"key":"9835_CR34","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.carbpol.2016.06.044","volume":"151","author":"AS de Medeiros","year":"2016","unstructured":"de Medeiros, A. S. et al. Supramolecular aggregates of oligosaccharides with co-solvents in ternary systems for the solubilizing approach of triamcinolone. Carbohydr. Polym. 151, 1040\u20131051 (2016).","journal-title":"Carbohydr. Polym."},{"key":"9835_CR35","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jmgm.2017.08.021","volume":"77","author":"B De Sousa","year":"2017","unstructured":"De Sousa, B. et al. Molecular modelling and quantum biochemistry computations of a naturally occurring bioremediation enzyme: alkane hydroxylase from Pseudomonas putida P1. J. Mol. Graph. Model. 77, 232\u2013239 (2017).","journal-title":"J. Mol. Graph. Model."},{"issue":"15","key":"9835_CR36","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.1039\/C9NJ06276A","volume":"44","author":"K Bezerra","year":"2020","unstructured":"Bezerra, K. et al. Interaction energies between two antiandrogenic and one androgenic agonist receptor in the presence of a T877A mutation in prostate cancer: a quantum chemistry analysis. New J. Chem. 44 (15), 5903\u20135912 (2020).","journal-title":"New J. Chem."},{"key":"9835_CR37","doi-asserted-by":"crossref","unstructured":"Psilopatis, I. et al. The emerging role of histone deacetylase inhibitors in cervical cancer therapy, Cancers, vol. 15, no. 8, p. 2222, (2023).","DOI":"10.3390\/cancers15082222"},{"issue":"4","key":"9835_CR38","doi-asserted-by":"publisher","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib, L., Wehner, M. R., Matrisian, L. M. & Nead, K. T. Estimated projection of US cancer incidence and death to 2040. JAMA Netw. Open. 4 (4), e214708\u2013e214708 (2021).","journal-title":"JAMA Netw. Open."},{"key":"9835_CR39","doi-asserted-by":"crossref","unstructured":"Kawsar, S. M., Kumer, A., Munia, N. S., Hosen, M. A., Chakma, U., & Akash, S. (2022). Chemical descriptors, PASS, molecular docking, molecular dynamics and ADMET predictions of glucopyranoside derivatives as inhibitors to bacteria and fungi growth. Organic Communications, 15(2), 203.","DOI":"10.25135\/acg.oc.122.2203.2397"},{"issue":"8","key":"9835_CR40","doi-asserted-by":"publisher","first-page":"e18279","DOI":"10.1111\/jcmm.18279","volume":"28","author":"M Shahab","year":"2024","unstructured":"Kumer, A., Sarker, N., Paul, S., & Zannat, A. (2019). The theoretical prediction of thermophysical properties, HOMO, LUMO, QSAR and biological indics of cannabinoids (CBD) and tetrahhdrocannabinol (THC) by computational chemistry. Advanced Journal of Chemistry-Section A, 2(3), 190-202.","journal-title":"J. Cell. Mol. Med."},{"issue":"9","key":"9835_CR41","doi-asserted-by":"publisher","first-page":"e18358","DOI":"10.1111\/jcmm.18358","volume":"28","author":"JZ Tayyeb","year":"2024","unstructured":"Kawsar, S., & Kumer, A. (2021). Computational investigation of methyl \u03b1-D-glucopyranoside derivatives as inhibitor against bacteria, fungi and COVID-19 (SARS-2). Journal of the Chilean Chemical Society, 66(2), 5206-5214.","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"9835_CR42","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/i3040276","volume":"3","author":"P Geerlings","year":"2002","unstructured":"Geerlings, P. & De Proft, F. Chemical reactivity as described by quantum chemical methods. Int. J. Mol. Sci. 3 (4), 276\u2013309 (2002).","journal-title":"Int. J. Mol. Sci."},{"key":"9835_CR43","doi-asserted-by":"crossref","unstructured":"Lagorce, D., Bouslama, L., Becot, J., Miteva, M. A. & Villoutreix, B. O. FAF-Drugs4: free ADME-tox filtering computations for chemical biology and early stages drug discovery, Bioinformatics, vol. 33, no. 22, pp. 3658\u20133660, (2017).","DOI":"10.1093\/bioinformatics\/btx491"},{"issue":"04","key":"9835_CR44","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1055\/s-0042-1759688","volume":"4","author":"S Babalola","year":"2022","unstructured":"Babalola, S., Igie, N. & Odeyemi, I. Molecular docking, Drug-Likeness analysis, in Silico pharmacokinetics, and toxicity studies of p-Nitrophenyl hydrazones as Anti-inflammatory compounds against COX-2, 5-LOX, and H+\/K\u2009+\u2009ATPase. Pharm. Fronts. 4 (04), e250\u2013e266 (2022).","journal-title":"Pharm. Fronts"},{"key":"9835_CR45","unstructured":"Wingelaar-Jagt, Y. Q., Bottenheft, C., Riedel, W. J. & Ramaekers, J. G. Reply to: modafinil: A closer look at its theoretical toxicological potential. Journal Psychopharmacol. (Oxford England), pp. 2698811231187127\u20132698811231187127, (2023)."},{"issue":"2","key":"9835_CR46","first-page":"183","volume":"3","author":"G. C. d. F Morais","year":"2022","unstructured":"Morais, G. . C. . d. F. et al. C. B. S. d. Oliveira, and toxicological potential of the fda-approved treatment against monkeypox. comment on Zovi. pharmacological agents with antiviral activity against monkeypox infection. Int. J. Mol. Sci. 3(2), 183\u2013186 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"9835_CR47","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2174\/15680266113139990033","volume":"13","author":"F Cheng","year":"2013","unstructured":"Cheng, F., Li, W., Liu, G. & Tang, Y. In Silico ADMET prediction: recent advances, current challenges and future trends. Curr. Top. Med. Chem. 13 (11), 1273\u20131289 (2013).","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"9835_CR48","first-page":"33","volume":"1","author":"FA Muslikh","year":"2023","unstructured":"Muslikh, F. A. et al. ADMET prediction of the dominant compound from mangosteen (Garcinia Mangostana L.) using pkcsm: A computational approach. Int. J. Contemp. Sci. (IJCS). 1 (1), 33\u201338 (2023).","journal-title":"Int. J. Contemp. Sci. (IJCS)"},{"issue":"W1","key":"9835_CR49","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu, L. et al. ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic acids research 52(W1), W422\u2013W431 (2024).","journal-title":"Nucleic acids research"},{"issue":"1","key":"9835_CR50","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1038\/s41598-025-86016-9","volume":"15","author":"G Sharma","year":"2025","unstructured":"Sharma, G. et al. Identification of promising SARS-CoV-2 main protease inhibitor through molecular docking, dynamics simulation, and ADMET analysis. Sci. Rep. 15 (1), 2830 (2025).","journal-title":"Sci. Rep."},{"key":"9835_CR51","doi-asserted-by":"crossref","unstructured":"Jurowski, K. et al. Toxicological profile of Acovenoside A as an active pharmaceutical ingredient\u2013prediction of missing key toxicological endpoints using in Silico toxicology methodology. Chemico-Biological Interactions, p. 111404, (2025).","DOI":"10.1016\/j.cbi.2025.111404"},{"issue":"6","key":"9835_CR52","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1080\/07391102.2023.2213333","volume":"42","author":"K Bhattacharya","year":"2024","unstructured":"Bhattacharya, K. et al. Computational Pharmacology profiling of Borapetoside C against melanoma. J. Biomol. Struct. Dynamics. 42 (6), 3233\u20133248 (2024).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"9835_CR53","doi-asserted-by":"crossref","unstructured":"Gaviraghi, G., Barnaby, R. J. & Pellegatti, M. Pharmacokinetic challenges in lead optimization, Pharmacokinetic optimization in drug research: Biological, physicochemical, and computational strategies, pp. 1\u201314, (2001).","DOI":"10.1002\/9783906390437.ch1"},{"issue":"7","key":"9835_CR54","doi-asserted-by":"publisher","first-page":"e23073","DOI":"10.1002\/jbt.23073","volume":"36","author":"PK Pasala","year":"2022","unstructured":"Pasala, P. K., Uppara, R. K., Rudrapal, M., Zothantluanga, J. H. & Umar, A. K. Silybin phytosome attenuates cerebral ischemia-reperfusion injury in rats by suppressing oxidative stress and reducing inflammatory response: in vivo and in Silico approaches. J. Biochem. Mol. Toxicol. 36 (7), e23073 (2022).","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"3","key":"9835_CR55","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1080\/10406638.2022.2046613","volume":"43","author":"JH Zothantluanga","year":"2023","unstructured":"Zothantluanga, J. H. et al. Computational investigations for identification of bioactive molecules from Baccaurea ramiflora and Bergenia ciliata as inhibitors of SARS-CoV-2 Mpro. Polycycl. Aromat. Compd. 43 (3), 2459\u20132487 (2023).","journal-title":"Polycycl. Aromat. Compd."},{"key":"9835_CR56","doi-asserted-by":"crossref","unstructured":"Kaya, S. & Putz, M. V. Atoms-in-molecules\u2019 faces of chemical hardness by conceptual density functional theory, Molecules, vol. 27, no. 24, p. 8825, (2022).","DOI":"10.3390\/molecules27248825"},{"key":"9835_CR57","doi-asserted-by":"crossref","unstructured":"Grochala, W. & Szarek, P. Lessons from the maximum hardness principle, in Chemical Reactivity: Elsevier, 277\u2013312. (2023).","DOI":"10.1016\/B978-0-32-390259-5.00016-0"},{"key":"9835_CR58","doi-asserted-by":"publisher","first-page":"929464","DOI":"10.3389\/fchem.2022.929464","volume":"10","author":"RA Miranda-Quintana","year":"2022","unstructured":"Miranda-Quintana, R. A. et al. Molecular interactions from the density functional theory for chemical reactivity: interaction chemical potential, hardness, and reactivity principles. Front. Chem. 10, 929464 (2022).","journal-title":"Front. Chem."},{"key":"9835_CR59","unstructured":"Rajasekaran, E., Meenal, R. & Indupriya, R. Internal Carbon of Chemical Molecules Play in Intermolecular Association Favoring Stability, Materials today: Proceedings, (2020)."},{"issue":"9","key":"9835_CR60","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1021\/ja983494x","volume":"121","author":"RG Parr","year":"1999","unstructured":"Parr, R. G., Szentp\u00e1ly, L. & Liu, S. Electrophilicity index. J. Am. Chem. Soc. 121 (9), 1922\u20131924 (1999).","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"9835_CR61","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s10910-023-01488-2","volume":"61","author":"N Flores-Gallegos","year":"2023","unstructured":"Flores-Gallegos, N. & Flores-G\u00f3mez, L. An approach to chemical hardness through shannon\u2019s entropy. J. Math. Chem. 61 (8), 1726\u20131738 (2023).","journal-title":"J. Math. Chem."},{"issue":"19","key":"9835_CR62","doi-asserted-by":"publisher","first-page":"11799","DOI":"10.3390\/ijms231911799","volume":"23","author":"DM Khaled","year":"2022","unstructured":"Khaled, D. M. et al. A computational QSAR, molecular Docking and in vitro cytotoxicity study of novel thiouracil-based drugs with anticancer activity against human-DNA topoisomerase II. Int. J. Mol. Sci. 23 (19), 11799 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"9835_CR63","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1073\/pnas.76.6.2522","volume":"76","author":"RG Parr","year":"1979","unstructured":"Parr, R. G., Gadre, S. R. & Bartolotti, L. J. Local density functional theory of atoms and molecules. Proceedings of the National Academy of Sciences 76(6), 2522\u20132526 (1979).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"9835_CR64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.drudis.2007.11.007","volume":"13","author":"G Vistoli","year":"2008","unstructured":"Vistoli, G., Pedretti, A. & Testa, B. Assessing drug-likeness\u2013what are we missing? Drug Discovery Today. 13, 7\u20138 (2008).","journal-title":"Drug Discovery Today"},{"issue":"14","key":"9835_CR65","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1021\/jm801331y","volume":"52","author":"C Laurence","year":"2009","unstructured":"Laurence, C., Brameld, K. A., Graton, J., Le Questel, J. Y. & Renault, E. The p K BHX database: toward a better Understanding of hydrogen-bond basicity for medicinal chemists. J. Med. Chem. 52 (14), 4073\u20134086 (2009).","journal-title":"J. Med. Chem."},{"issue":"5","key":"9835_CR66","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1371\/journal.pone.0000468","volume":"2","author":"Y Savir","year":"2007","unstructured":"Savir, Y. & Tlusty, T. Conformational proofreading: the impact of conformational changes on the specificity of molecular recognition. PloS One. 2 (5), e468 (2007).","journal-title":"PloS One"},{"issue":"8","key":"9835_CR67","doi-asserted-by":"publisher","first-page":"e1003782","DOI":"10.1371\/journal.pcbi.1003782","volume":"10","author":"X Chu","year":"2014","unstructured":"Chu, X. & Wang, J. Specificity and affinity quantification of flexible recognition from underlying energy landscape topography. PLoS Comput. Biol. 10 (8), e1003782 (2014).","journal-title":"PLoS Comput. Biol."},{"issue":"8","key":"9835_CR68","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1208\/s12249-018-1188-8","volume":"19","author":"V Patel","year":"2018","unstructured":"Patel, V., Lalani, R., Bardoliwala, D., Ghosh, S. & Misra, A. Lipid-based oral formulation strategies for lipophilic drugs. Aaps Pharmscitech. 19 (8), 3609\u20133630 (2018).","journal-title":"Aaps Pharmscitech"},{"issue":"12","key":"9835_CR69","doi-asserted-by":"publisher","first-page":"101870","DOI":"10.1016\/j.jsps.2023.101870","volume":"31","author":"S Sambhakar","year":"2023","unstructured":"Sambhakar, S. et al. Exploring lipids for their potential to improves bioavailability of lipophilic drugs candidates: A review. Saudi Pharm. J. 31 (12), 101870 (2023).","journal-title":"Saudi Pharm. J."},{"key":"9835_CR70","doi-asserted-by":"crossref","unstructured":"Lopez-Toledano, M. A. et al. Advanced lipid technologies\u00ae(ALT\u00ae): A proven formulation platform to enhance the bioavailability of lipophilic compounds, Journal of drug delivery, vol. no. 1, p. 1957360, (2019).","DOI":"10.1155\/2019\/1957360"},{"issue":"12","key":"9835_CR71","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1021\/tx700319t","volume":"20","author":"JR Huth","year":"2007","unstructured":"Huth, J. R. et al. Toxicological evaluation of thiol-reactive compounds identified using a La assay to detect reactive molecules by nuclear magnetic resonance. Chem. Res. Toxicol. 20 (12), 1752\u20131759 (2007).","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"9835_CR72","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/ijms22020646","volume":"22","author":"Z Kej\u00edk","year":"2021","unstructured":"Kej\u00edk, Z. et al. Iron complexes of flavonoids-antioxidant capacity and beyond. Int. J. Mol. Sci. 22 (2), 646 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"9835_CR73","doi-asserted-by":"publisher","first-page":"972198","DOI":"10.3389\/fchem.2022.972198","volume":"10","author":"VJ Lee","year":"2022","unstructured":"Lee, V. J. & Heffern, M. C. Structure-activity assessment of flavonoids as modulators of copper transport. Front. Chem. 10, 972198 (2022).","journal-title":"Front. Chem."},{"issue":"8","key":"9835_CR74","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.2174\/1570180820666230224112505","volume":"21","author":"N Lohit","year":"2024","unstructured":"Lohit, N. et al. Description and in Silico ADME studies of US-FDA approved drugs or drugs under clinical trial which violate the lipinski\u2019s rule of 5. Lett. Drug Des. Discovery. 21 (8), 1334\u20131358 (2024).","journal-title":"Lett. Drug Des. Discovery"},{"issue":"4","key":"9835_CR75","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1021\/ci034043l","volume":"43","author":"Y Takaoka","year":"2003","unstructured":"Takaoka, Y. et al. Development of a method for evaluating drug-likeness and ease of synthesis using a data set in which compounds are assigned scores based on chemists\u2019 intuition. J. Chem. Inf. Comput. Sci. 43 (4), 1269\u20131275 (2003).","journal-title":"J. Chem. Inf. Comput. Sci."},{"issue":"4","key":"9835_CR76","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/minf.201000118","volume":"30","author":"H Pham The","year":"2011","unstructured":"Pham The, H. et al. In Silico prediction of Caco-2 cell permeability by a classification QSAR approach. Mol. Inf. 30 (4), 376\u2013385 (2011).","journal-title":"Mol. Inf."},{"issue":"6","key":"9835_CR77","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1021\/ci7002076","volume":"47","author":"T Hou","year":"2007","unstructured":"Hou, T., Wang, J. & Li, Y. ADME evaluation in drug discovery. 8. The prediction of human intestinal absorption by a support vector machine. J. Chem. Inf. Model. 47 (6), 2408\u20132415 (2007).","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"9835_CR78","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.ejpb.2012.02.012","volume":"81","author":"A Beig","year":"2012","unstructured":"Beig, A., Miller, J. M. & Dahan, A. Accounting for the solubility\u2013permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorption. Eur. J. Pharm. Biopharm. 81 (2), 386\u2013391 (2012).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"9835_CR79","doi-asserted-by":"publisher","first-page":"105541","DOI":"10.1016\/j.ejps.2020.105541","volume":"155","author":"C Keefer","year":"2020","unstructured":"Keefer, C. et al. Mechanistic insights on clearance and Inhibition discordance between liver microsomes and hepatocytes when clearance in liver microsomes is higher than in hepatocytes. Eur. J. Pharm. Sci. 155, 105541 (2020).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"9","key":"9835_CR80","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1002\/jps.23614","volume":"102","author":"T Bohnert","year":"2013","unstructured":"Bohnert, T. & Gan, L. S. Plasma protein binding: from discovery to development. J. Pharm. Sci. 102 (9), 2953\u20132994 (2013).","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"9835_CR81","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","volume":"181","author":"Z Zhao","year":"2020","unstructured":"Zhao, Z. et al. Targeting strategies for tissue-specific drug delivery. Cell 181(1), 151\u2013167 (2020).","journal-title":"Cell"},{"issue":"2","key":"9835_CR82","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1517\/17425255.2011.545053","volume":"7","author":"M Pellegatti","year":"2011","unstructured":"Pellegatti, M. & Pagliarusco, S. Drug and metabolite concentrations in tissues in relationship to tissue adverse findings: a review. Expert Opin. Drug Metab. Toxicol. 7 (2), 137\u2013146 (2011).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"9835_CR83","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2165\/00003088-200038010-00003","volume":"38","author":"GK Dresser","year":"2000","unstructured":"Dresser, G. K., Spence, J. D. & Bailey, D. G. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 Inhibition. Clin. Pharmacokinet. 38, 41\u201357 (2000).","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"9835_CR84","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1124\/pr.115.011411","volume":"68","author":"JT Backman","year":"2016","unstructured":"Backman, J. T., Filppula, A. M., Niemi, M. & Neuvonen, P. J. Role of cytochrome P450 2C8 in drug metabolism and interactions. Pharmacol. Rev. 68 (1), 168\u2013241 (2016).","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"9835_CR85","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger, U. M. & Schwab, M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol. Ther. 138 (1), 103\u2013141 (2013).","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"9835_CR86","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nrd2378","volume":"6","author":"JA Kramer","year":"2007","unstructured":"Kramer, J. A., Sagartz, J. E. & Morris, D. L. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates. Nat. Rev. Drug Discovery. 6 (8), 636\u2013649 (2007).","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"7083","key":"9835_CR87","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature04710","volume":"440","author":"MC Sanguinetti","year":"2006","unstructured":"Sanguinetti, M. C. & Tristani-Firouzi, M. hERG potassium channels and cardiac arrhythmia. Nature 440 (7083), 463\u2013469 (2006).","journal-title":"Nature"},{"issue":"1","key":"9835_CR88","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1021\/tx900326k","volume":"23","author":"D Fourches","year":"2010","unstructured":"Fourches, D. et al. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem. Res. Toxicol. 23 (1), 171\u2013183 (2010).","journal-title":"Chem. Res. Toxicol."},{"key":"9835_CR89","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00204-020-02733-2","volume":"94","author":"A Hartwig","year":"2020","unstructured":"Hartwig, A. et al. Mode of action-based risk assessment of genotoxic carcinogens. Arch. Toxicol. 94, 1787\u20131877 (2020).","journal-title":"Arch. Toxicol."},{"issue":"1","key":"9835_CR90","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.watres.2010.08.019","volume":"45","author":"BI Escher","year":"2011","unstructured":"Escher, B. I. et al. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res. 45 (1), 75\u201392 (2011).","journal-title":"Water Res."},{"issue":"23","key":"9835_CR91","doi-asserted-by":"publisher","first-page":"8684","DOI":"10.1021\/acs.jcim.4c01116","volume":"64","author":"HJ Lee","year":"2024","unstructured":"Lee, H. J., Emani, P. S. & Gerstein, M. B. Improved prediction of Ligand\u2013Protein binding affinities by Meta-modeling. J. Chem. Inf. Model. 64 (23), 8684\u20138704 (2024).","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"9835_CR92","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1021\/bi002160t","volume":"40","author":"U Koch","year":"2001","unstructured":"Koch, U. et al. Role of charged residues in the catalytic mechanism of hepatitis C virus NS3 protease: electrostatic precollision guidance and transition-state stabilization. Biochemistry 40(3), 631\u2013640 (2001).","journal-title":"Biochemistry"},{"key":"9835_CR93","doi-asserted-by":"crossref","unstructured":"Bhatia, M. Exploring Flavone Reactivity: A Quantum Mechanical Study and TDDFT Benchmark on UV-Vis Spectroscopy, (2024).","DOI":"10.26434\/chemrxiv-2024-xsnqj"},{"key":"9835_CR94","doi-asserted-by":"crossref","unstructured":"Kumaree, K. K., Anthikapalli, N. V. A. & Prasansuklab, A. In silico screening for potential inhibitors from the phytocompounds of Carica papaya against Zika virus NS5 protein, F1000Research, vol. 12, p. 655, (2024).","DOI":"10.12688\/f1000research.134956.2"},{"issue":"5","key":"9835_CR95","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/17425255.2021.1902986","volume":"17","author":"T Murakami","year":"2021","unstructured":"Murakami, T., Bodor, E. & Bodor, N. Factors and dosage formulations affecting the solubility and bioavailability of P-glycoprotein substrate drugs. Expert Opin. Drug Metab. Toxicol. 17 (5), 555\u2013580 (2021).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"3","key":"9835_CR96","first-page":"145","volume":"4","author":"M Bouachrine","year":"2021","unstructured":"Bouachrine, M. et al. Molecular docking, drug likeness studies and ADMET prediction of flavonoids as platelet-activating factor (PAF) receptor binding. Chem. Rev. Lett. 4 (3), 145\u2013152 (2021).","journal-title":"Chem. Rev. Lett."},{"issue":"3","key":"9835_CR97","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1515\/tjb-2018-0002","volume":"44","author":"N Rasool","year":"2019","unstructured":"Rasool, N., Ashraf, A., Waseem, M., Hussain, W. & Mahmood, S. Computational exploration of antiviral activity of phytochemicals against NS2B\/NS3 proteases from dengue virus. Turkish J. Biochem. 44 (3), 261\u2013277 (2019).","journal-title":"Turkish J. Biochem."},{"key":"9835_CR98","unstructured":"Akash, S., Arefin, F. & Aovi, F. I. In silico investigation of potential therapeutic medication for the inhibition of dengue virus (DENV NS2B\/NS3 and NS1) by modification of polycyclic quaternary alkaloid (sanguinarine derivatives) with different computational approaches, globe, vol. 3, p. 5, (2020)."},{"issue":"1","key":"9835_CR99","doi-asserted-by":"publisher","first-page":"12933","DOI":"10.1038\/s41598-020-69515-9","volume":"10","author":"P Songprakhon","year":"2020","unstructured":"Songprakhon, P. et al. Peptides targeting dengue viral nonstructural protein 1 inhibit dengue virus production. Sci. Rep. 10 (1), 12933 (2020).","journal-title":"Sci. Rep."},{"issue":"19","key":"9835_CR100","doi-asserted-by":"publisher","first-page":"11131","DOI":"10.3390\/ijms231911131","volume":"23","author":"MK Dassanayake","year":"2022","unstructured":"Dassanayake, M. K., Khoo, T. J., Chong, C. H. & Di Martino, P. Molecular Docking and in-silico analysis of natural biomolecules against dengue, ebola, zika, SARS-CoV-2 variants of concern and Monkeypox virus. Int. J. Mol. Sci. 23 (19), 11131 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"9835_CR101","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/biophysica3010006","volume":"3","author":"MV Saivish","year":"2023","unstructured":"Saivish, M. V. et al. Structural Insights into Plasticity and Discovery of Flavonoid Allosteric Inhibitors of Flavivirus NS2B\u2013NS3 Protease. Biophysica 3(1), 71\u201392 (2023).","journal-title":"Biophysica"},{"issue":"4","key":"9835_CR102","doi-asserted-by":"publisher","first-page":"660","DOI":"10.56499\/jppres22.1375_10.4.660","volume":"10","author":"RR Renantha","year":"2022","unstructured":"Renantha, R. R. et al. Flavonoids as potential inhibitors of dengue virus 2 (DENV2) envelope protein. J. Pharm. Pharmacogn Res. 10 (4), 660\u2013675 (2022).","journal-title":"J. Pharm. Pharmacogn Res."},{"key":"9835_CR103","doi-asserted-by":"crossref","unstructured":"Tambe, V., Ditani, A., Rajpoot, K. & Tekade, R. K. Pharmacokinetics aspects of structural modifications in drug design and therapy, in Biopharmaceutics and Pharmacokinetics Considerations: Elsevier, 83\u2013108. (2021).","DOI":"10.1016\/B978-0-12-814425-1.00014-0"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09835-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09835-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09835-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T23:06:50Z","timestamp":1757286410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09835-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9835"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09835-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26922"}}